CELLULAR BIOMEDICINE GROUP I's ticker is and the CUSIP is 15117P952. A total of 2 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | – | 560 | +378.6% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 117 | +680.0% | 0.00% | – |
Q1 2020 | $23,000 | -68.5% | 15 | -66.7% | 0.00% | – |
Q4 2019 | $73,000 | +356.2% | 45 | +309.1% | 0.00% | – |
Q3 2019 | $16,000 | +23.1% | 11 | +37.5% | 0.00% | – |
Q2 2019 | $13,000 | +160.0% | 8 | +166.7% | 0.00% | – |
Q1 2019 | $5,000 | +66.7% | 3 | +50.0% | 0.00% | – |
Q4 2018 | $3,000 | -66.7% | 2 | -60.0% | 0.00% | – |
Q3 2018 | $9,000 | +200.0% | 5 | +150.0% | 0.00% | – |
Q2 2018 | $3,000 | – | 2 | -80.0% | 0.00% | – |
Q1 2018 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 2 | $3,000 | 0.00% |